Kaleido Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2016 | 0 | -9.68M | |
|---|---|---|---|
| 2017 | 0 | -27.55M | |
| 2018 | 0 | -61.74M | |
| 2019 | 0 | -85.01M | |
| 2020 | 975K | -79.79M | -8184.21% |
| 2021 | 1.10M | -93.27M | -8448.46% |
| 2022 | 0 | 0 |
KLDO Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 1.10M | 975K | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 2.35M | 55.96K | 1.31M | 0 | 0 | 0 |
Gross profit | 0 | -1.25M | 919.03K | -1.31M | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 0 | 67.80M | 55.96M | 64.23M | 42.06M | 20.99M | 7.86M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 88.77M | 79.84M | 86.66M | 60.68M | 27.03M | 9.43M |
Operating income | 0 | -87.66M | -78.87M | -86.66M | -60.68M | -27.03M | -9.43M |
Other income (expenses), net | 0 | -2.62M | -2.74M | 329K | -1.17M | -529K | -108K |
Income before tax | 0 | -90.28M | -81.61M | -86.33M | -61.74M | -27.55M | -9.68M |
Income tax expense | 0 | 2.98M | -1.82M | -1.31M | -56K | -94K | 139K |
Net income | 0 | -93.27M | -79.79M | -85.01M | -61.74M | -27.55M | -9.68M |
Earnings per share | |||||||
Basic EPS | 0 | -2.23 | -2.39 | -3.31 | -2.1 | -1.23 | -0.43 |
Diluted EPS | 0 | -2.23 | -2.39 | -3.31 | -2.1 | -1.23 | -0.43 |
| Data source | Data source | Data source |